bibliographicCitation |
Scott EN, Meinhardt G, Jacques C, Laurent D, Thomas AL. Vatalanib: the clinical development of a tyrosine kinase inhibitor of angiogenesis in solid tumours. Expert Opinion on Investigational Drugs. 2007 Feb 16;16(3):367–79. doi: 10.1517/13543784.16.3.367. |